Genetic variations in TMEM106b, GRN and SORT1 do not correlate with DNA methylation levels in amplicon A-1 and GRN mRNA expression/net secretion in LCLs.
SNPs for TMEM rs1990622 (a), GRN rs5848 (b) and SORT1 rs646776 (c) were analyzed by Taqman genotyping assays or PCR amplification with subsequent sequencing. Patients with different genetic variants did not show any difference in GRN promoter methylation in amplicon A-1 (left panel) . GRN mRNA expression levels were quantified by qPCR and normalized to PGK1. GRN mRNA expression levels did not differ in patients with different genetic variants (center panel). GRN net secretion was quantified by ELISA and did not differ in LCLs with different genotypes (right panel). Mean SD, ANOVA, Student's t-test. 
Treatment with the DNMT-inhibitor 5-aza-2'-deoxycytidine (DAC) significantly increases GRN mRNA and protein expression in the murine microglia cell line BV-2.
Treatment of the murine microglia cell line BV-2 with 0.13 µM DAC for 9 days significantly increased GRN mRNA expression, while GRN expression in control treated cells did not change. GRN mRNA expression levels were quantified by qPCR and normalized to PGK1. Mean SD, n=3, * p<0.05, **p<0.01, ***p<0.001, Student's t-test. 
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